Trials / Completed
CompletedNCT05802901
The Effect of Combining Spinal Manipulation and Dry Needling in Individuals With Low Back Pain
The Effect of Combining Spinal Manipulation and Dry Needling in Individuals With Non-specific Low Back
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- University of Utah · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to enroll and randomize 99 participants with non-specific low back pain into a multimodal strategy of treatment consisting of a combination of dry needling (DN) and spinal manipulation therapy (SMT), DN only, and SMT only, followed by an at home exercise program. All groups will receive their respective treatment twice a week for 2 weeks followed by a 2-week home exercise program. Primary outcomes include clinical subjective (Oswestry Disability Index, numeric pain intensity rating) and mechanistic (lumbar multifidus, erector spinae, and gluteus medius muscle activation) measures assessed at baseline, 1, 2, and 4 weeks. Timepoints at 2-weeks and 4-weeks will be compared to baseline measures to determine effectiveness of the combination group against the other single treatment groups. Exercise compliance will be measured by participants self-reporting adherence to the program by selecting average number of days per week the exercises are completed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Spinal manipulation | Spinal manipulation of the lumbar spine only to be performed in the spinal manipulation arm/group. |
| PROCEDURE | Dry needling | Dry needling of the lumbar erector spinae, multifidus, and gluteus medius on the symptomatic side performed in the dry needling arm/group. |
| PROCEDURE | Spinal manipulation and dry needling | The spinal manipulation and dry needling arm/group receive both spinal manipulation and dry needling as outlined in the other groups. |
Timeline
- Start date
- 2021-02-28
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2023-04-07
- Last updated
- 2023-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05802901. Inclusion in this directory is not an endorsement.